The main goal for the coming 3 years was approved at the General Assembly meeting of the Ukrainian Community Advisory Board (UCAB) on February, 10 — 11, 2012, which states: To ensure that all patients get […]
For more than a year already international and patient organizations tried to get precise information from Mili Healthcare pharmaceutical company about their new biosimilar product Peginterferon for HCV treatment. This drug was registered […]
During the meeting of UCAB members and state bodies’ representatives for the first time an agreement on the inclusion of patients into the group under the Ministry of Health of Ukraine (MoH) responsible for the list […]
The first meeting of Ukrainian Community Advisory Board (UCAB) and the representatives of pharmaceutical company took place on April, 19-21. The first company, who met the community, was Abbott Laboratories Ltd.
During the meeting of Ukrainian Community Advisory Board (UCAB) with the representatives of Gilead Sciences, an opportunity to supply in-kind drugs donation for more than 3,000 Ukrainian patients living with HIV was discussed.
New player in pharmaceutical market of Ukraine On January 31-st the first open meeting of UCAB — a specialized board of patients for lobbying their interests in front of pharmaceutical companies — took place.